New York, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Mid-Revenue Cycle Management / Clinical Documentation Improvement Industry" - https://www.reportlinker.com/p06357942/?utm_source=GNW
4 Billion by 2027, growing at aCAGR of 6.5% over the period 2020-2027. Solutions, one of the segments analyzed in the report, is projected to record 6.4% CAGR and reach US$4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Consulting Service segment is readjusted to a revised 6.7% CAGR for the next 7-year period.
The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 10.5% CAGR
The Mid-Revenue Cycle Management / Clinical Documentation Improvement market in the U.S. is estimated at US$1.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2027 trailing a CAGR of 10.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.1% and 5.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.
Select Competitors (Total 36 Featured) -
3M Company
Optum, Inc.
Nuance Communications, Inc.
M*Modal
Dolbey Systems
Nthrive, Inc.
Streamline Health Solutions, LLC
Vitalware, LLC.
Chartwise Medical Systems, Inc.
Iodine Software
Craneware
Epic Systems
Cerner
eZDI Inc.
Flash Code
TruCode
Read the full report: https://www.reportlinker.com/p06357942/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Mid-Revenue Cycle Management/Clinical Documentation Improvement -
Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for Mid-Revenue Cycle Management/
Clinical Documentation Improvement by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 3: World 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets for Years 2012, 2021 & 2027
Table 4: World Recent Past, Current & Future Analysis for
Solutions by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR
Table 5: World Historic Review for Solutions by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 6: World 15-Year Perspective for Solutions by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027
Table 7: World Recent Past, Current & Future Analysis for
Consulting Service by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR
Table 8: World Historic Review for Consulting Service by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 9: World 15-Year Perspective for Consulting Service by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 10: World Recent Past, Current & Future Analysis for
Healthcare Providers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR
Table 11: World Historic Review for Healthcare Providers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 12: World 15-Year Perspective for Healthcare Providers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 13: World Recent Past, Current & Future Analysis for
Healthcare Payers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR
Table 14: World Historic Review for Healthcare Payers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 15: World 15-Year Perspective for Healthcare Payers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 16: World Mid-Revenue Cycle Management / Clinical
Documentation Improvement Market Analysis of Annual Sales in
US$ Million for Years 2012 through 2027
III. MARKET ANALYSIS
UNITED STATES
Mid-Revenue Cycle Management / Clinical Documentation
Improvement Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in the United States for 2022 (E)
Table 17: USA Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by Component - Solutions and Consulting Service -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 18: USA Historic Review for Mid-Revenue Cycle Management/
Clinical Documentation Improvement by Component - Solutions
and Consulting Service Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 19: USA 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Component -
Percentage Breakdown of Value Sales for Solutions and
Consulting Service for the Years 2012, 2021 & 2027
Table 20: USA Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by End-Use - Healthcare Providers and Healthcare
Payers - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR
Table 21: USA Historic Review for Mid-Revenue Cycle Management/
Clinical Documentation Improvement by End-Use - Healthcare
Providers and Healthcare Payers Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 22: USA 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by End-Use -
Percentage Breakdown of Value Sales for Healthcare Providers
and Healthcare Payers for the Years 2012, 2021 & 2027
CANADA
Table 23: Canada Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by Component - Solutions and Consulting Service -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 24: Canada Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Component -
Solutions and Consulting Service Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 25: Canada 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Component -
Percentage Breakdown of Value Sales for Solutions and
Consulting Service for the Years 2012, 2021 & 2027
Table 26: Canada Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by End-Use - Healthcare Providers and Healthcare
Payers - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR
Table 27: Canada Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by End-Use -
Healthcare Providers and Healthcare Payers Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 28: Canada 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by End-Use -
Percentage Breakdown of Value Sales for Healthcare Providers
and Healthcare Payers for the Years 2012, 2021 & 2027
JAPAN
Mid-Revenue Cycle Management / Clinical Documentation
Improvement Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Japan for 2022 (E)
Table 29: Japan Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by Component - Solutions and Consulting Service -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 30: Japan Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Component -
Solutions and Consulting Service Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 31: Japan 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Component -
Percentage Breakdown of Value Sales for Solutions and
Consulting Service for the Years 2012, 2021 & 2027
Table 32: Japan Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by End-Use - Healthcare Providers and Healthcare
Payers - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR
Table 33: Japan Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by End-Use -
Healthcare Providers and Healthcare Payers Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 34: Japan 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by End-Use -
Percentage Breakdown of Value Sales for Healthcare Providers
and Healthcare Payers for the Years 2012, 2021 & 2027
CHINA
Mid-Revenue Cycle Management / Clinical Documentation
Improvement Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in China for 2022 (E)
Table 35: China Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by Component - Solutions and Consulting Service -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 36: China Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Component -
Solutions and Consulting Service Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 37: China 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Component -
Percentage Breakdown of Value Sales for Solutions and
Consulting Service for the Years 2012, 2021 & 2027
Table 38: China Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by End-Use - Healthcare Providers and Healthcare
Payers - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR
Table 39: China Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by End-Use -
Healthcare Providers and Healthcare Payers Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 40: China 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by End-Use -
Percentage Breakdown of Value Sales for Healthcare Providers
and Healthcare Payers for the Years 2012, 2021 & 2027
EUROPE
Mid-Revenue Cycle Management / Clinical Documentation
Improvement Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Europe for 2022 (E)
Table 41: Europe Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR
Table 42: Europe Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Geographic
Region - France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 43: Europe 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Geographic
Region - Percentage Breakdown of Value Sales for France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets
for Years 2012, 2021 & 2027
Table 44: Europe Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by Component - Solutions and Consulting Service -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 45: Europe Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Component -
Solutions and Consulting Service Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 46: Europe 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Component -
Percentage Breakdown of Value Sales for Solutions and
Consulting Service for the Years 2012, 2021 & 2027
Table 47: Europe Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by End-Use - Healthcare Providers and Healthcare
Payers - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR
Table 48: Europe Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by End-Use -
Healthcare Providers and Healthcare Payers Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 49: Europe 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by End-Use -
Percentage Breakdown of Value Sales for Healthcare Providers
and Healthcare Payers for the Years 2012, 2021 & 2027
FRANCE
Mid-Revenue Cycle Management / Clinical Documentation
Improvement Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in France for 2022 (E)
Table 50: France Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by Component - Solutions and Consulting Service -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 51: France Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Component -
Solutions and Consulting Service Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 52: France 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Component -
Percentage Breakdown of Value Sales for Solutions and
Consulting Service for the Years 2012, 2021 & 2027
Table 53: France Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by End-Use - Healthcare Providers and Healthcare
Payers - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR
Table 54: France Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by End-Use -
Healthcare Providers and Healthcare Payers Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 55: France 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by End-Use -
Percentage Breakdown of Value Sales for Healthcare Providers
and Healthcare Payers for the Years 2012, 2021 & 2027
GERMANY
Mid-Revenue Cycle Management / Clinical Documentation
Improvement Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Germany for 2022 (E)
Table 56: Germany Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by Component - Solutions and Consulting Service -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 57: Germany Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Component -
Solutions and Consulting Service Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 58: Germany 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Component -
Percentage Breakdown of Value Sales for Solutions and
Consulting Service for the Years 2012, 2021 & 2027
Table 59: Germany Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by End-Use - Healthcare Providers and Healthcare
Payers - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR
Table 60: Germany Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by End-Use -
Healthcare Providers and Healthcare Payers Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 61: Germany 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by End-Use -
Percentage Breakdown of Value Sales for Healthcare Providers
and Healthcare Payers for the Years 2012, 2021 & 2027
ITALY
Table 62: Italy Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by Component - Solutions and Consulting Service -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 63: Italy Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Component -
Solutions and Consulting Service Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 64: Italy 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Component -
Percentage Breakdown of Value Sales for Solutions and
Consulting Service for the Years 2012, 2021 & 2027
Table 65: Italy Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by End-Use - Healthcare Providers and Healthcare
Payers - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR
Table 66: Italy Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by End-Use -
Healthcare Providers and Healthcare Payers Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 67: Italy 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by End-Use -
Percentage Breakdown of Value Sales for Healthcare Providers
and Healthcare Payers for the Years 2012, 2021 & 2027
UNITED KINGDOM
Mid-Revenue Cycle Management / Clinical Documentation
Improvement Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in the United Kingdom for 2022 (E)
Table 68: UK Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by Component - Solutions and Consulting Service -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 69: UK Historic Review for Mid-Revenue Cycle Management /
Clinical Documentation Improvement by Component - Solutions and
Consulting Service Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 70: UK 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Component -
Percentage Breakdown of Value Sales for Solutions and
Consulting Service for the Years 2012, 2021 & 2027
Table 71: UK Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by End-Use - Healthcare Providers and Healthcare
Payers - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR
Table 72: UK Historic Review for Mid-Revenue Cycle Management /
Clinical Documentation Improvement by End-Use - Healthcare
Providers and Healthcare Payers Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 73: UK 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by End-Use -
Percentage Breakdown of Value Sales for Healthcare Providers
and Healthcare Payers for the Years 2012, 2021 & 2027
SPAIN
Table 74: Spain Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by Component - Solutions and Consulting Service -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 75: Spain Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Component -
Solutions and Consulting Service Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 76: Spain 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Component -
Percentage Breakdown of Value Sales for Solutions and
Consulting Service for the Years 2012, 2021 & 2027
Table 77: Spain Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by End-Use - Healthcare Providers and Healthcare
Payers - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR
Table 78: Spain Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by End-Use -
Healthcare Providers and Healthcare Payers Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 79: Spain 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by End-Use -
Percentage Breakdown of Value Sales for Healthcare Providers
and Healthcare Payers for the Years 2012, 2021 & 2027
RUSSIA
Table 80: Russia Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by Component - Solutions and Consulting Service -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 81: Russia Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Component -
Solutions and Consulting Service Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 82: Russia 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Component -
Percentage Breakdown of Value Sales for Solutions and
Consulting Service for the Years 2012, 2021 & 2027
Table 83: Russia Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by End-Use - Healthcare Providers and Healthcare
Payers - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR
Table 84: Russia Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by End-Use -
Healthcare Providers and Healthcare Payers Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 85: Russia 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by End-Use -
Percentage Breakdown of Value Sales for Healthcare Providers
and Healthcare Payers for the Years 2012, 2021 & 2027
REST OF EUROPE
Table 86: Rest of Europe Recent Past, Current & Future Analysis
for Mid-Revenue Cycle Management / Clinical Documentation
Improvement by Component - Solutions and Consulting Service -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 87: Rest of Europe Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Component -
Solutions and Consulting Service Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 88: Rest of Europe 15-Year Perspective for Mid-Revenue
Cycle Management / Clinical Documentation Improvement by
Component - Percentage Breakdown of Value Sales for Solutions
and Consulting Service for the Years 2012, 2021 & 2027
Table 89: Rest of Europe Recent Past, Current & Future Analysis
for Mid-Revenue Cycle Management / Clinical Documentation
Improvement by End-Use - Healthcare Providers and Healthcare
Payers - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR
Table 90: Rest of Europe Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by End-Use -
Healthcare Providers and Healthcare Payers Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 91: Rest of Europe 15-Year Perspective for Mid-Revenue
Cycle Management / Clinical Documentation Improvement by
End-Use - Percentage Breakdown of Value Sales for Healthcare
Providers and Healthcare Payers for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Mid-Revenue Cycle Management / Clinical Documentation
Improvement Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Asia-Pacific for 2022 (E)
Table 92: Asia-Pacific Recent Past, Current & Future Analysis
for Mid-Revenue Cycle Management / Clinical Documentation
Improvement by Geographic Region - Australia, India, South
Korea and Rest of Asia-Pacific Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR
Table 93: Asia-Pacific Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Geographic
Region - Australia, India, South Korea and Rest of Asia-Pacific
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR
Table 94: Asia-Pacific 15-Year Perspective for Mid-Revenue
Cycle Management / Clinical Documentation Improvement by
Geographic Region - Percentage Breakdown of Value Sales for
Australia, India, South Korea and Rest of Asia-Pacific Markets
for Years 2012, 2021 & 2027
Table 95: Asia-Pacific Recent Past, Current & Future Analysis
for Mid-Revenue Cycle Management / Clinical Documentation
Improvement by Component - Solutions and Consulting Service -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 96: Asia-Pacific Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Component -
Solutions and Consulting Service Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 97: Asia-Pacific 15-Year Perspective for Mid-Revenue
Cycle Management / Clinical Documentation Improvement by
Component - Percentage Breakdown of Value Sales for Solutions
and Consulting Service for the Years 2012, 2021 & 2027
Table 98: Asia-Pacific Recent Past, Current & Future Analysis
for Mid-Revenue Cycle Management / Clinical Documentation
Improvement by End-Use - Healthcare Providers and Healthcare
Payers - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR
Table 99: Asia-Pacific Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by End-Use -
Healthcare Providers and Healthcare Payers Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 100: Asia-Pacific 15-Year Perspective for Mid-Revenue
Cycle Management / Clinical Documentation Improvement by
End-Use - Percentage Breakdown of Value Sales for Healthcare
Providers and Healthcare Payers for the Years 2012, 2021 & 2027
AUSTRALIA
Mid-Revenue Cycle Management / Clinical Documentation
Improvement Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Australia for 2022 (E)
Table 101: Australia Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by Component - Solutions and Consulting Service -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 102: Australia Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Component -
Solutions and Consulting Service Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 103: Australia 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Component -
Percentage Breakdown of Value Sales for Solutions and
Consulting Service for the Years 2012, 2021 & 2027
Table 104: Australia Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by End-Use - Healthcare Providers and Healthcare
Payers - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR
Table 105: Australia Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by End-Use -
Healthcare Providers and Healthcare Payers Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 106: Australia 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by End-Use -
Percentage Breakdown of Value Sales for Healthcare Providers
and Healthcare Payers for the Years 2012, 2021 & 2027
INDIA
Mid-Revenue Cycle Management / Clinical Documentation
Improvement Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in India for 2022 (E)
Table 107: India Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by Component - Solutions and Consulting Service -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 108: India Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Component -
Solutions and Consulting Service Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 109: India 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Component -
Percentage Breakdown of Value Sales for Solutions and
Consulting Service for the Years 2012, 2021 & 2027
Table 110: India Recent Past, Current & Future Analysis for
Mid-Revenue Cycle Management / Clinical Documentation
Improvement by End-Use - Healthcare Providers and Healthcare
Payers - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR
Table 111: India Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by End-Use -
Healthcare Providers and Healthcare Payers Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 112: India 15-Year Perspective for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by End-Use -
Percentage Breakdown of Value Sales for Healthcare Providers
and Healthcare Payers for the Years 2012, 2021 & 2027
SOUTH KOREA
Table 113: South Korea Recent Past, Current & Future Analysis
for Mid-Revenue Cycle Management / Clinical Documentation
Improvement by Component - Solutions and Consulting Service -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 114: South Korea Historic Review for Mid-Revenue Cycle
Management / Clinical Documentation Improvement by Component -
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06357942/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
